Tag Archives: FLXS

Top 5 Medical Stocks To Buy For 2019

After five deals in six months, Bank of Nova Scotia is taking a breather.

“We’ve got a lot of work to do in terms of execution and integrations now, so I think we’ll be fairly quiet on the acquisition front from here on in,” Chief Executive Officer Brian Porter told BNN Bloomberg on Friday in a TV interview set to air at 3 p.m. Eastern time.

On Thursday, Scotiabank agreed to buy MD Financial Management from the Canadian Medical Association for C$2.59 billion ($2 billion), the latest in a series of announced acquisitions that include Canadian money manager Jarislowsky Fraser Ltd. and Banco Bilbao Vizcaya Argentaria SA’s 68 percent stake in a Chilean lender.

The purchase of Ottawa-based MD Financial will add a wealth-management business with C$49 billion in assets and 110,000 clients, including affluent doctors, the Toronto-based bank — Canada’s third-largest — said Thursday in a statement. Also on Thursday, Scotiabank sold 19.7 million shares to raise about C$1.5 billion to help pay for the deal, an offering Porter said was “very well received."

Top 5 Medical Stocks To Buy For 2019: Dynatronics Corporation(DYNT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    News articles about Dynatronics (NASDAQ:DYNT) have trended somewhat positive this week, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dynatronics earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news coverage about the medical equipment provider an impact score of 45.8383718108453 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Dynatronics (DYNT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Dynatronics (NASDAQ: DYNT) and Rockwell Medical (NASDAQ:RMTI) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends and earnings.

Top 5 Medical Stocks To Buy For 2019: Estee Lauder Companies, Inc. (EL)

Advisors’ Opinion:

  • [By Garrett Baldwin]

    Click here to learn more…

    Stocks to Watch Today: DIS, TMUS, BP, S
    Shares of Walt Disney Co. (NYSE: DIS) will lead a busy day of earnings reports. Wall Street is expecting a small decline in revenue for the first quarter. Disney is still in the process of absorbing most of Fox’s assets from a deal last June. In addition, Disney will be launching its streaming service, Disney+, and investors will be looking for updates on the project. In deal news, T-Mobile U.S. Inc. (NYSE: TMUS) is looking to sweeten an offer to regulators to ensure a merger with rival Sprint Corp. (NYSE: S). The telecom giant told the U.S. Federal Communications Commission that it would freeze the prices of many plans if it receives approval for a deal. T-Mobile has offered $26 billion to buy Sprint. Shares of BP Plc. (NYSE: BP) rallied more than 3.7% after the global energy giant topped 2018 earnings expectations. The firm’s big bets on shale developments have paid off. Profitability more than doubled over the previous year, while production topped out at 3.7 million barrels per day. Look for earnings reports from Allstate Corp. (NYSE: ALL), Anadarko Petroleum Corp. (NYSE: APC), Archer Daniels Midland Co. (NYSE: ADM), Becton, Dickenson & Co. (NYSE: BDX), BP Plc. (NYSE: BP), Chubb Ltd. (NYSE: CB), Digital Realty Trust (NYSE: DLR), Emerson Electric Co. (NYSE: EMR), Estee Lauder Co. Inc. (NYSE: EL), Lazard Ltd. (NYSE: LAZ), Pitney Bowes Inc. (NYSE: PBI), Plains All American Pipeline LP (NYSE: PAA), Ralph Lauren Corp. (NYSE: RL), Snap Inc. (NYSE: SNAP), and Tableau Software Inc. (NASDAQ: DATA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

  • [By Jeremy Bowman]

    The share price of Estee Lauder (NYSE:EL), the 73-year-old global giant, has risen 76% over the last three years, and the company just delivered another impressive quarterly report. At a time when many bricks-and-mortar retailers are struggling, salon and cosmetics chain Ulta Beauty (NASDAQ:ULTA) is fast opening up stores, and its shares have more than tripled in the last five years. Sales of luxury beauty products have been growing particularly fast, driving excellent performance for companies like Estee Lauder and Coty (NYSE: COTY).

  • [By Joseph Griffin]

    Estée Lauder Companies (NYSE:EL) had its price objective cut by Credit Suisse Group from $162.00 to $156.00 in a report issued on Thursday morning. They currently have an outperform rating on the stock.

  • [By Motley Fool Staff]

    The cast reaches for the mailbag in this segment from Industry Focus: Consumer Goods. Listener Joseph wants to know why Estée Lauder (NYSE:EL) and Ulta Beauty (NASDAQ:ULTA), both leading names in the skincare and cosmetics industry, have seen their stocks move in opposite directions over the past year.

Top 5 Medical Stocks To Buy For 2019: James Hardie Industries plc.(JHX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about James Hardie Industries (NYSE:JHX) have been trending somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm rates the sentiment of media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. James Hardie Industries earned a coverage optimism score of 0.16 on Accern’s scale. Accern also assigned press coverage about the construction company an impact score of 45.4803891697197 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Top 5 Medical Stocks To Buy For 2019: Flexsteel Industries, Inc.(FLXS)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Purple Innovation (NASDAQ: FLXS) and Flexsteel Industries (NASDAQ:FLXS) are both small-cap unclassified companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitability, analyst recommendations and valuation.

  • [By Logan Wallace]

    Flexsteel Industries, Inc. (NASDAQ:FLXS) hit a new 52-week low during trading on Monday . The stock traded as low as $30.57 and last traded at $30.38, with a volume of 1359 shares. The stock had previously closed at $31.53.

  • [By Shane Hupp]

    BidaskClub cut shares of Flexsteel Industries (NASDAQ:FLXS) from a hold rating to a sell rating in a research report released on Friday morning.

    Separately, ValuEngine lowered shares of Flexsteel Industries from a hold rating to a sell rating in a research report on Friday, April 27th.

Top 5 Medical Stocks To Buy For 2019: Lazard World Dividend & Income Fund, Inc.(LOR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Lazard World Dividend & Income Fund, Inc common stock (NYSE:LOR) have trended somewhat negative this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Lazard World Dividend & Income Fund, Inc common stock earned a media sentiment score of -0.03 on Accern’s scale. Accern also gave media headlines about the company an impact score of 48.1658217953419 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Top Casino Stocks To Own Right Now

&l;p&g;Imagine you are at a roulette table in a casino and are given an opportunity for your lifetime savings of $500,000. You have two choices, A and B. If you choose option A, you will receive a monthly paycheck of $2,000 for the rest of your life. With option B, you could receive a monthly paycheck of $5,000 for the rest of your life.

The choice seems obvious, right? Not quite. If you read it correctly, option B does not offer the certainty of option A. The word &a;lsquo;could&a;rsquo; expresses possibility &a;ndash; and only possibility. That means there is a risk involved &a;ndash; a spin on the wheel. If it lands on red, you will receive the $5,000 monthly paycheck for the rest of your life, but if it lands on black, you receive nothing. Now, what do you do? Is the reward worth the risk?

That is the BIG question! Since I began focusing on income planning in 2005, four out of five clients I meet face this decision: the known versus the unknown, the certainty of a paycheck versus the possibility of making more money in the market. We refer to it as &a;lsquo;income planning&a;rsquo; versus &a;lsquo;income guessing.&a;rsquo;

Top Casino Stocks To Own Right Now: Flexsteel Industries, Inc.(FLXS)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub cut shares of Flexsteel Industries (NASDAQ:FLXS) from a hold rating to a sell rating in a research report released on Friday morning.

    Separately, ValuEngine lowered shares of Flexsteel Industries from a hold rating to a sell rating in a research report on Friday, April 27th.

Top Casino Stocks To Own Right Now: AeroCentury Corp.(ACY)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TheStreet downgraded shares of AeroCentury (NYSEAMERICAN:ACY) from a b rating to a c rating in a report issued on Wednesday morning.

    Separately, Zacks Investment Research raised shares of AeroCentury from a sell rating to a hold rating in a research note on Monday, February 12th.

Top Casino Stocks To Own Right Now: Lexicon Pharmaceuticals, Inc.(LXRX)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Lexicon Pharmaceuticals (LXRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Lexicon Pharmaceuticals (NASDAQ:LXRX) – Analysts at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Lexicon Pharmaceuticals in a note issued to investors on Monday, May 7th. Wedbush analyst L. Moussatos expects that the biopharmaceutical company will earn ($0.28) per share for the quarter. Wedbush currently has a “Outperform” rating and a $40.00 target price on the stock. Wedbush also issued estimates for Lexicon Pharmaceuticals’ Q2 2019 earnings at ($0.25) EPS, Q3 2019 earnings at ($0.13) EPS, Q4 2019 earnings at ($0.06) EPS, FY2020 earnings at $0.53 EPS, FY2021 earnings at $2.22 EPS and FY2022 earnings at $3.81 EPS.

Top Casino Stocks To Own Right Now: Bel Fuse Inc.(BELFB)

Advisors’ Opinion:

  • [By Logan Wallace]

    ValuEngine cut shares of Bel Fuse (NASDAQ:BELFB) from a buy rating to a hold rating in a research note published on Wednesday.

    Separately, BidaskClub lowered shares of Bel Fuse from a sell rating to a strong sell rating in a research note on Saturday, January 6th.

Top Casino Stocks To Own Right Now: Enbridge Inc(ENB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Schaper Benz & Wise Investment Counsel Inc. WI lifted its position in Enbridge (NYSE:ENB) (TSE:ENB) by 19.1% in the first quarter, HoldingsChannel reports. The institutional investor owned 116,204 shares of the pipeline company’s stock after buying an additional 18,674 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI’s holdings in Enbridge were worth $3,657,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    QCI Asset Management Inc. NY lifted its stake in Enbridge (NYSE:ENB) (TSE:ENB) by 60.2% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 598,684 shares of the pipeline company’s stock after acquiring an additional 225,030 shares during the quarter. Enbridge makes up 2.0% of QCI Asset Management Inc. NY’s portfolio, making the stock its 11th biggest holding. QCI Asset Management Inc. NY’s holdings in Enbridge were worth $18,841,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Matthew DiLallo]

    Several high-yielding dividend stocks have taken it on the chin this year due to a sell-off in the stock market and rising interest rates. That one-two punch has hit pipeline stocks the hardest, with several top-notch companies tumbling by a double-digit percentage since the start of the year. Three that stand out as excellent options to consider buying now that they’re on sale are Magellan Midstream Partners (NYSE:MMP), Antero Midstream Partners (NYSE:AM), and Enbridge (NYSE:ENB).

  • [By Joseph Griffin]

    Enbridge (NYSE:ENB) (TSE:ENB) is scheduled to be releasing its earnings data before the market opens on Thursday, May 10th. Analysts expect Enbridge to post earnings of $0.48 per share for the quarter.

  • [By Matthew DiLallo]

    This growth helped more than offset a loss in the company’s “other” segment, which used to house its Midcoast gas gathering and processing business. Last year the MLP sold that entity back to its parent Enbridge (NYSE:ENB), and Enbridge unloaded it this week.

Top Casino Stocks To Own Right Now: Citigroup Inc.(C)

Advisors’ Opinion:

  • [By Eric Volkman]

    The underwriting syndicate is large and star-studded. It is led by Morgan Stanley (NYSE: MS), JPMorgan Chase’s(NYSE:JPM)J.P. Morgan Securities, Barclays (NYSE: BCS) Capital, and Citigroup (NYSE: C) Global Markets.

  • [By Tim Melvin]

    Last Friday, the first wave of bank earnings reports hit Wall Street, when JPMorgan Chase & Co. (NYSE: JPM), Citigroup Inc. (NYSE: C), and scandal-stricken Wells Fargo & Co. (NYSE: WFC) released their first-quarter financials.

  • [By Shane Hupp]

    A number of institutional investors and hedge funds have recently modified their holdings of the business. Principal Financial Group Inc. boosted its position in shares of Citigroup by 17.3% during the 3rd quarter. Principal Financial Group Inc. now owns 4,869,619 shares of the financial services provider’s stock worth $354,216,000 after purchasing an additional 717,320 shares in the last quarter. Prudential Financial Inc. boosted its position in shares of Citigroup by 17.0% during the 3rd quarter. Prudential Financial Inc. now owns 7,514,341 shares of the financial services provider’s stock worth $546,594,000 after purchasing an additional 1,092,980 shares in the last quarter. C WorldWide Group Holding A S boosted its position in shares of Citigroup by 13.1% during the 3rd quarter. C WorldWide Group Holding A S now owns 6,603,267 shares of the financial services provider’s stock worth $480,322,000 after purchasing an additional 764,249 shares in the last quarter. Macquarie Group Ltd. boosted its position in shares of Citigroup by 3.7% during the 3rd quarter. Macquarie Group Ltd. now owns 363,594 shares of the financial services provider’s stock worth $26,448,000 after purchasing an additional 13,019 shares in the last quarter. Finally, Harvey Capital Management Inc. boosted its position in shares of Citigroup by 47.6% during the 3rd quarter. Harvey Capital Management Inc. now owns 124,635 shares of the financial services provider’s stock worth $9,065,000 after purchasing an additional 40,195 shares in the last quarter. 80.13% of the stock is currently owned by institutional investors and hedge funds.

    COPYRIGHT VIOLATION NOTICE: “Investors Sell Citigroup (C) on Strength (C)” was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was copied illegally and republished in violation of international trademark & cop

  • [By ]

    TheStreet’s founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with the financial results from JPMorgan Chase (JPM) and Citigroup (C) .

Top 5 Stocks To Watch For 2018

Many workers look forward to retirement and the more laid-back lifestyle it allows for. But if you retire before you’re actually ready, you could wind up majorly regretting that decision. With that in mind, here are a few signs that you’re not actually prepared to retire — even if you think you are.

1. You haven’t saved enough

Maybe you’re sitting on a nest egg with several hundred thousand dollars and are thinking you’re in good shape for retirement. But while, say, a $300,000 savings balance is nothing to scoff at, it most likely won’t buy you the retirement lifestyle you’re hoping for.

For years, financial experts have been suggesting a 4% annual withdrawal rate from savings during retirement. Withdrawing roughly 4% of your nest egg each year is, based on historical data, likely to make it last for 30 years. But if you apply a 4% withdrawal rate to a $300,000 savings balance, that only gives you $12,000 a year, which is hardly enough to live on.

Image source: Getty Images.

Top 5 Stocks To Watch For 2018: Avery Dennison Corporation(AVY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Strategy Asset Managers LLC acquired a new stake in Avery Dennison (NYSE:AVY) during the first quarter, HoldingsChannel.com reports. The firm acquired 23,500 shares of the industrial products company’s stock, valued at approximately $2,497,000.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Avery Dennison (AVY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Stocks To Watch For 2018: Flexsteel Industries, Inc.(FLXS)

Advisors’ Opinion:

  • [By Shane Hupp]

    BidaskClub cut shares of Flexsteel Industries (NASDAQ:FLXS) from a hold rating to a sell rating in a research report released on Friday morning.

    Separately, ValuEngine lowered shares of Flexsteel Industries from a hold rating to a sell rating in a research report on Friday, April 27th.

Top 5 Stocks To Watch For 2018: FS Bancorp, Inc.(FSBW)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on FS Bancorp (FSBW)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    FS Bancorp (NASDAQ:FSBW) – Research analysts at FIG Partners boosted their Q2 2018 earnings estimates for FS Bancorp in a research report issued to clients and investors on Thursday, May 3rd. FIG Partners analyst T. Coffey now anticipates that the bank will post earnings per share of $1.16 for the quarter, up from their prior forecast of $1.13. FIG Partners also issued estimates for FS Bancorp’s FY2018 earnings at $4.70 EPS, Q1 2019 earnings at $1.08 EPS, Q4 2019 earnings at $1.33 EPS and FY2019 earnings at $5.09 EPS.

Top 5 Stocks To Watch For 2018: bluebird bio, Inc.(BLUE)

Advisors’ Opinion:

  • [By Brian Orelli]

    bluebird bio (NASDAQ:BLUE) reportedfirst-quarter earnings last week, but like the biotech typically does, management didn’t hold a conference call, which makes the earnings release more of a rehash of the quarter than an actual update.

  • [By Ethan Ryder]

    Blue Protocol (CURRENCY:BLUE) traded down 9.1% against the U.S. dollar during the 24-hour period ending at 11:00 AM Eastern on May 12th. One Blue Protocol token can now be purchased for about $0.18 or 0.00002166 BTC on cryptocurrency exchanges including CoinExchange, EtherDelta (ForkDelta), IDEX and YoBit. In the last seven days, Blue Protocol has traded down 16.3% against the U.S. dollar. Blue Protocol has a market capitalization of $6.65 million and $31,443.00 worth of Blue Protocol was traded on exchanges in the last 24 hours.

  • [By Keith Speights]

    Over the last 12 months, bluebird bio (NASDAQ:BLUE) stock has more than doubled. During the same period, Ziopharm Oncology’s (NASDAQ:ZIOP) share price has tumbled over 30%. That’s the past, though. Which of these two clinical-stage biotech stocks is the better pick for investors now?

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Todd Campbell, Leo Sun, and Daniel Miller]

    For instance, the company recently acquired Juno Therapeutics to get its hands on a pipeline of chimeric antigen receptor T-cell gene therapies (CAR-Ts). CAR-Ts represent one of the biggest recent advances in treating blood cancer, and depending on trial results, the first CAR-T from this collaboration could be filed for approval next year. Similarly, Celgene is partnering with bluebird bio (NASDAQ:BLUE) on bb2121, a CAR-T for multiple myeloma. So far, bb2121 is delivering 90%-plus response rates in heavily pre-treated patients, and if that success continues, it could end up on regulators’ desk for approval next year, too.

Top 5 Stocks To Watch For 2018: SPDR S&P Bank ETF (KBE)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of KELLOGG W K FOUNDATION TRUST’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=KELLOGG+W+K+FOUNDATION+TRUST

    These are the top 5 holdings of KELLOGG W K FOUNDATION TRUSTKellogg Co (K) – 67,606,838 shares, 98.23% of the total portfolio. Shares reduced by 0.48%SPDR Select Sector Fund – Energy Select Sector (XLE) – 769,255 shares, 1.19% of the total portfolio. SPDR S&P Bank (KBE) – 534,408 shares, 0.54% of the total portfolio. Shares reduced by 37.08%MuleSoft Inc (MULE) – 73,513 shares, 0.04% of the total portfolio. New PositioniShares Russell 1000 Value (IWD) – 0 shares, 0% of the total portfol